News
Omada Health shows strong growth and innovation in chronic care but remains unprofitable with valuation, churn. See why OMDA ...
The EU faces a surge in new opioids and designer drugs, while the U.S. fast-tracks rare disease drugs. Brazil tackles bird ...
Omada Health shares popped more than 30% in their Nasdaq debut on Friday after the virtual chronic care company priced its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results